People · Operator
Named in public records as an officer, director or promoter · active 2014–2019 · Pharmaceuticals
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| AltaThera Pharmaceuticals, LLC | — | Pharmaceuticals | Seed | $7.6M | $58.3M | 2014 |
Brandon Kashfian at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Brandon Kashfian on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| John Flavin | 1 | 4 |
| Rick White | 1 | 4 |
| Stephen O'Sullivan | 1 | 1 |
| James Wittenberg | 1 | 1 |
| Mahlaqa Patel | 1 | 1 |
| Merrill Bardin | 1 | 1 |
| Jay Welsh | 1 | 1 |
| Jodi Devlin | 1 | 1 |
| Stephen Osullivan | 1 | 1 |
| John Somberg | 1 | 1 |
| Merrill Barden | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.